Recital 7, Regulation (EU) 2024/2750

In forcesince 25 Oct 2024

The Commission concurs with the opinion of the Agency and considers it therefore appropriate to grant a Union authorisation for ‘LANXESS CMIT/MIT biocidal product family’.